Yang Lu

发表

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia

Min Wang, Jianxiang Wang, Wei Liu, 2020, Journal of Hematology & Oncology.

A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy

Q. Rao, H. Xing, Z. Tian, 2022, Experimental Hematology & Oncology.

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells

Jianxiang Wang, Xiaolong Zhang, M. Hao, 2019, Journal of Hematology & Oncology.

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan

Xiaolong Zhang, D. Xiong, Leisheng Zhang, 2017, Journal of Hematology & Oncology.

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

Jianxiang Wang, M. Hao, D. Xiong, 2021, Frontiers in Oncology.

Surface expression of anti‐CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A‐engineered human umbilical cord mesenchymal stem cells

Xiao-Long Zhang, Yang Lu, D. Fan, 2017, International journal of cancer.

Identification of Novel MicroRNA Signatures Linked to Experimental Autoimmune Myasthenia Gravis Pathogenesis: Down-Regulated miR-145 Promotes Pathogenetic Th17 Cell Response

D. Geng, Xiuying Zhang, Jiao Wang, 2013, Journal of Neuroimmune Pharmacology.

Identification of Novel MicroRNA Signatures Linked to Experimental Autoimmune Myasthenia Gravis Pathogenesis: Down-Regulated miR-145 Promotes Pathogenetic Th17 Cell Response

Jing Chen, Xiuming Zhang, Y. Qiao, 2013, Journal of Neuroimmune Pharmacology.

Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection

Z. Rao, Ping Zhu, Jiaxi Zhou, 2023, Nature communications.

Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection

Hong Wang, Ping Zhu, Jiaxi Zhou, 2023, Immunity.

A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma

Jianxiang Wang, Xiaomin Lei, Xiaolong Zhang, 2021, Journal of immunotherapy.

Multi-dimensional Dissection of Blood Components reveals an Uncanonical Immune Landscape in SARS-CoV-2 Omicron Patients

Hong Wang, Ping Zhu, Jiaxi Zhou, 2023 .

Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinoma

D. Xiong, Lei Yang, Yang Lu, 2023, Oncoimmunology.